NRP1 and Mobius syndrome: Remarkably, we found that targeting PDE4D to inhibit the newly discovered Sema3-Nrp-PDE4D-PKA pathway powerfully blocks the growth of Hh-related MBs that are resistant to Smo inhibitors.